Ravi Mhatre is Director at Nutanix, Inc. (NTNX). They have made 12 open-market trades across 6 companies since 2007, most recently 2026-07-13.
CIK 0001366050
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.0M since 2018, against 11 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 40% | 60% |
| Avg Move | +0.4% | +11.1% | +30.2% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RBRK | SELL | 2026-07-13 | 2026-07-14 | $83.10 | $331K | -18.4% | +17.2% | +33.8% |
| RBRK | SELL | 2026-06-26 | 2026-06-26 | $71.49 | $284K | +20.3% | +1.4% | +54.3% |
| RBRK | SELL | 2025-12-12 | 2025-12-15 | $81.82 | $16.6M | +0.6% | -12.8% | -33.9% |
| RBRK | SELL | 2025-12-12 | 2026-01-16 | $85.27 | $453K | -11.9% | -18.7% | -21.1% |
| RBRK | SELL | 2025-06-30 | 2025-07-02 | $89.47 | $3.0M | +1.5% | +1.9% | -4.4% |
| RBRK | SELL | 2025-04-15 | 2025-04-17 | $62.98 | $1.7M | +15.1% | +41.5% | +42.7% |
| RBRK | SELL | 2024-09-13 | 2024-09-17 | $30.19 | $962K | +0.2% | +23.8% | +136.7% |
| NTNX | SELL | 2019-12-09 | 2019-12-10 | $33.56 | $12.8M | -4.1% | +3.5% | -47.0% |
| FTSV | BUY | 2018-08-22 | 2018-08-24 | $15.12 | $2.0M | -7.5% | -11.3% | +2.2% |
| SFIX | SELL | 2018-07-03 | 2018-07-09 | $27.97 | $9.2M | +5.2% | -8.1% | -20.5% |
| NMBL | SELL | 2014-07-03 | 2014-07-08 | $29.23 | $1.2M | -20.2% | -3.4% | -3.4% |
| RVBD | SELL | 2007-07-31 | 2007-08-01 | $44.10 | $3.2M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| FIO | 7,969,507 | — |
| RVBD | 68,203 | — |
| Total | $544.7M |
Shares reported on the most recent Form 4, priced at the 2026-06-05 close. 2 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.